Chinook Therapeutics (KDNY)
NASDAQ:KDNY
Holding KDNY?
Track your performance easily

Chinook Therapeutics (KDNY) Ownership - Who Owns Chinook Therapeutics?

459 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 19, 2023
Jerel Davis
Director
xxxxxxxxxxxxx
$6138016
Dec 15, 2022
Eric Dobmeier
President & Ceo,director
xxxxxxxxxxxxx
$10500
Sep 06, 2022
Thomas Dolca
Director
xxxxxxxxxxxxx
$212194

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2023
xxxxxxxxxxxxx
$831154
Jun 30, 2023
xxxxxxxxxxxxx
$17486028
Jun 30, 2023
xxxxxxxxxxxxx
$33687926

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,475Institution<0.01%29,913

FAQ

Who Owns Chinook Therapeutics (KDNY)?
Currently, no data Available
What percentage of Chinook Therapeutics (KDNY) stock is held by institutional investors?
Currently, no data Available
What percentage of Chinook Therapeutics (KDNY) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Chinook Therapeutics (KDNY)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis